Zimelidine

This article is a stub. You can help us by editing it and adding accurate information.

Zimelidine is an SSRI antidepressant that used to be prescribed in the 1980s. In very rare cases, it caused Guillain–Barré syndrome, a condition that can lead to paralysis and even death. This serious issue slowed research into SSRI medications, causing the FDA to be more cautious about approving new medications.

See also

• Selective serotonin reuptake inhibitor

References

Antidepressants

Monoamine oxidase inhibitors: Harmaline • Nialamide • Selegiline • Isocarboxazid • Iproniazid • Iproclozide • Moclobemide • Phenelzine • Toloxatone • Tranylcypromine Dopamine reuptake inhibitors: Bupropion • Amineptine Norepinephrine reuptake inhibitors: Atomoxetine • Reboxetine • Viloxazine • Maprotiline Serotonin-norepinephrine reuptake inhibitors: Desipramine • Duloxetine • Milnacipran • Nefazodone • Venlafaxine Selective serotonin reuptake inhibitors: Alaproclate • Etoperidone • Citalopram • Escitalopram • Fluoxetine • Fluvoxamine • Paroxetine • Sertraline • Zimelidine Selective serotonin reuptake enhancers: Tianeptine Tricyclic antidepressants: Amitriptyline • Clomipramine • Desipramine • Dothiepin • Doxepin • Imipramine • Lofepramine • Nortriptyline • Protriptyline • Trimipramine • Iprindole • Opipramol Tetracyclic antidepressants: Maprotiline • Mianserin • Mirtazapine • Amoxapine